Literature DB >> 26811830

Some Facts about Case Fatality of Acute Myocardial Infarction in Iran.

Abdollah Mohammadian-Hafshejani1, Hamid Salehiniya2, Salman Khazaei3.   

Abstract

Entities:  

Year:  2015        PMID: 26811830      PMCID: PMC4724752     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

Cardiovascular disease is the first cause of death in the world and Iran (1). These diseases have increasing trends particularly in low-and moderate-income countries. According to international reports, mortality from AMI have rising trend (2), and cardiovascular disease (CAD) will remain among the three main causes of the global burden of disease to 2030 (3). Despite a significant reduction in the amount of prevalence of coronary heart disease in many countries and advances in the treatment of patients, case fatality rate following the occurrence of acute myocardial infarction in both sexes has remained high (4, 5). Thus, identifying the most frequent and fatal myocardial infarction and the most important factors influencing survival could have important role in reducing deaths from the disease. In Iran, short-term (28-day) survival rate of patient with first acute myocardial infarction in average was 91%, in male 92.5% and 86.7% in female (6, 7). The most frequent and fatal myocardial infarction was anterior wall acute myocardial infarction and acute transmural myocardial infarction of unspecified site, respectively (8, 9). Men, young’s and patients with acute subendocardial myocardial infarction had the highest survival rate and women, elderly and patients with acute transmural myocardial infarction of unspecified site have the most hazard ratio of mortality (Table 1) (10). Therefore, with regard to the identification of the most common and fatal and in addition, the most important factors affecting the survival of patients from acute myocardial infarction, should physicians and other health care providers have more attention to this patients. Accordingly, we can finally reduce the case fatality and number of patients that death from this disease.
Table 1:

Hazard ratio of case fatality rate from acute myocardial infarction in Isfahan, central Iran

VariablesHazard ratio (Confidence interval 95%)P-value
Age (yr)1.05 (1.04–1.06)<0.001
Acute subendocardial myocardial infarction1
Acute transmural myocardial infarction of other sites2.32 (1.23–4.37)<0.001
Acute transmural myocardial infarction of inferior wall2.6 (1.74–3.91)<0.001
Acute transmural myocardial infarction of anterior wall4 (2.7–5.9)<0.001
Acute myocardial infarction, unspecified8.8 (5.9–12.9)<0.001
Acute transmural myocardial infarction of unspecified site18 (10.6 –30.5)<0.001
Men1
Women1.4 (1.23–1.6)<0.001
Hazard ratio of case fatality rate from acute myocardial infarction in Isfahan, central Iran
  5 in total

1.  Secular trends in cardiovascular mortality in Iran, with special reference to Isfahan.

Authors:  N Sarraf-Zadegan; M Boshtam; H Malekafzali; N Bashardoost; F A Sayed-Tabatabaei; M Rafiei; A Khalili; S Mostafavi; M Khami; R Hassanvand
Journal:  Acta Cardiol       Date:  1999-12       Impact factor: 1.718

Review 2.  The burden and costs of chronic diseases in low-income and middle-income countries.

Authors:  Dele O Abegunde; Colin D Mathers; Taghreed Adam; Monica Ortegon; Kathleen Strong
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321

3.  Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden.

Authors:  S Z Abildstrom; S Rasmussen; M Rosén; M Madsen
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

4.  Projections of global mortality and burden of disease from 2002 to 2030.

Authors:  Colin D Mathers; Dejan Loncar
Journal:  PLoS Med       Date:  2006-11       Impact factor: 11.069

5.  Seasonal pattern in admissions and mortality from acute myocardial infarction in elderly patients in Isfahan, Iran.

Authors:  Abdollah Mohammadian-Hafshejani; Nizal Sarrafzadegan; Shidokht Hosseini; Hamid Reza Baradaran; Hamidreza Roohafza; Masoumeh Sadeghi; Mohsen Asadi-Lari
Journal:  ARYA Atheroscler       Date:  2014-01
  5 in total
  1 in total

1.  Acute management of stroke in Iran: Obstacles and solutions.

Authors:  Shima Shahjouei; Reza Bavarsad-Shahripour; Farhad Assarzadegan; Reza Rikhtegar; Masoud Mehrpour; Babak Zamani; Georgios Tsivgoulis; Andrei Alexandrov; Anne Alexandrov; Ramin Zand
Journal:  Iran J Neurol       Date:  2017-04-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.